A share price of Cognition Therapeutics Inc [CGTX] is currently trading at $2.37, down -2.47%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CGTX shares have lost -16.99% over the last week, with a monthly amount glided 232.03%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cognition Therapeutics Inc [NASDAQ: CGTX] stock has seen the most recent analyst activity on December 19, 2024, when B. Riley Securities upgraded its rating to a Buy and also boosted its price target to $1.50 from $1. Previously, Cantor Fitzgerald downgraded its rating to Neutral on July 30, 2024. On November 03, 2021, Oppenheimer initiated with a Outperform rating and assigned a price target of $22 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $27 on November 03, 2021.
Cognition Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.22 and $3.83. Cognition Therapeutics Inc [NASDAQ: CGTX] shares were valued at $2.37 at the most recent close of the market.
Analyzing the CGTX fundamentals
Gross Profit Margin for this corporation currently stands at -0.99% with Operating Profit Margin at -211.76%, Pretax Profit Margin comes in at -131.97%, and Net Profit Margin reading is -131.97%. To continue investigating profitability, this company’s Return on Assets is posted at -1.68, Equity is -2.51 and Total Capital is -7.29. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.27 points at the first support level, and at 2.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.47, and for the 2nd resistance point, it is at 2.57.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cognition Therapeutics Inc [NASDAQ:CGTX] is 1.54. In addition, the Quick Ratio stands at 1.54 and the Cash Ratio stands at 0.87.
Transactions by insiders
Recent insider trading involved Ricciardi Lisa, CEO & President, that happened on Jan 31 ’25 when 38851.0 shares were purchased.
